CXCR4 and cancer: CXCR4-CXCL12 signaling has been associated with the polarization towards an immune-suppressive microenvironment: the possible role of a CXCL12 shield that protects cancer cells from being recognized by cytotoxic lymphocytes and activates regulatory T-cells has recently been described6.